Future Science GroupBrowse
Supplementary Figure 1.docx (44.88 kB)
Download file

Supplementary Figure 1. Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries

Download (44.88 kB)
figure
posted on 2021-10-20, 08:18 authored by Karl M. Kilgore, Iman Mohammadi, Anny C. Wong, Julia Thornton Snider, Paul Cheng, Amy Schroeder, Anik R. Patel
Supplementary Figure 1. Overall Survival, Relative to Start of 2nd LOT, ASCT-Intended, Stratified by Time-to-Relapse

Funding

Kite, A Gilead Company, Santa Monica, CA

History

Usage metrics

Read the peer-reviewed publication

Burden of Illness & Outcomes in 2nd Line Large B-Cell Lymphoma Treatment: Real-world Analysis of Medicare Beneficiaries
Future OncologyFuture Oncology

Categories

Keywords

Economic burdenMedicarelarge B-cell lymphomaline of therapystem-cell transplanttreatment patternsCancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0

Exports